These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 8253062)
1. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. Hoess A; Watson S; Siber GR; Liddington R EMBO J; 1993 Sep; 12(9):3351-6. PubMed ID: 8253062 [TBL] [Abstract][Full Text] [Related]
2. Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide. Andrä J; Garidel P; Majerle A; Jerala R; Ridge R; Paus E; Novitsky T; Koch MH; Brandenburg K Eur J Biochem; 2004 May; 271(10):2037-46. PubMed ID: 15128313 [TBL] [Abstract][Full Text] [Related]
3. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor. Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014 [TBL] [Abstract][Full Text] [Related]
4. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor. Ried C; Wahl C; Miethke T; Wellnhofer G; Landgraf C; Schneider-Mergener J; Hoess A J Biol Chem; 1996 Nov; 271(45):28120-7. PubMed ID: 8910426 [TBL] [Abstract][Full Text] [Related]
5. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo. Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780 [TBL] [Abstract][Full Text] [Related]
6. A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases. Vallespi MG; Glaria LA; Reyes O; Garay HE; Ferrero J; Araña MJ Clin Diagn Lab Immunol; 2000 Jul; 7(4):669-75. PubMed ID: 10882670 [TBL] [Abstract][Full Text] [Related]
7. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor. Leslie DB; Vietzen PS; Lazaron V; Wasiluk KR; Dunn DL Surg Infect (Larchmt); 2006 Feb; 7(1):45-52. PubMed ID: 16509785 [TBL] [Abstract][Full Text] [Related]
16. Identification of the LPS-binding domain of an endotoxin neutralising protein, Limulus anti-LPS factor. Hoess A; Schneider-Mergener J; Liddington RC Prog Clin Biol Res; 1995; 392():327-37. PubMed ID: 8524938 [No Abstract] [Full Text] [Related]
17. Physicochemical and biological characterization of anti-endotoxin peptides and their influence on lipid properties. Kowalski I; Kaconis Y; Andrä J; Razquin-Olazarán I; Gutsmann T; Martinez de Tejada G; Brandenburg K Protein Pept Lett; 2010 Nov; 17(11):1328-33. PubMed ID: 20673224 [TBL] [Abstract][Full Text] [Related]
18. Reversible binding of heparin to the loop peptide of endotoxin neutralizing protein. Ridge RJ; Paus EJ; Novitsky TJ; Ketchum PA J Endotoxin Res; 2000; 6(1):17-23. PubMed ID: 11061028 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis. Andrä J; Howe J; Garidel P; Rössle M; Richter W; Leiva-León J; Moriyon I; Bartels R; Gutsmann T; Brandenburg K Biochem J; 2007 Sep; 406(2):297-307. PubMed ID: 17501719 [TBL] [Abstract][Full Text] [Related]
20. Anti-LPS factor in the horseshoe crab, Tachypleus tridentatus. Its hemolytic activity on the red blood cell sensitized with lipopolysaccharide. Ohashi K; Niwa M; Nakamura T; Morita T; Iwanaga S FEBS Lett; 1984 Oct; 176(1):207-10. PubMed ID: 6386521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]